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Osteoarthritis (OA) is a frequent and disabling rheumatic condi-
tion. Its diagnosis relies mainly on clinical examination and imaging.
Most of the time, there is a discrepancy between patient symptoms
and the appearance of the joint structural changes on either X-ray or
magnetic resonance imaging (MRI). There is an obvious need for
speciﬁc biomarkers that could be useful for diagnostic purposes,
detectable at an early disease stage, and that could predict and follow
disease progression1. In addition, speciﬁc biomarkers could also be
useful tools to evaluate treatment efﬁcacy of disease modifying OA
drugs (DMOAD).
Collagen degradation is one of the main features of cartilage
breakdown during OA. Type II collagen degradation product is
a speciﬁc OA biomarker that can assess both disease progression
and activity1,2. Speciﬁc immunoassays have been developed to
measure a speciﬁc peptide located in the triple helix, Coll2-1 and its
nitrated form Coll2-1NO2, a marker associated with local oxidative
stress3,4. These biomarkers have been studied in vivo in mouse,
guinea pig and horse5e8 and also in healthy human3 and OA
patients4,9. The serum concentrations of these biomarkers wereto: Y. Henrotin, Bone and
man, B-4000 Liège, Belgium.
ax: 32-4-3664734.
.
s Research Society International. Pcompared to the serum concentration of myeloperoxidase (MPO),
a marker of neutrophil activation.
The aim of this study was to measure the changes over time of
both Coll2-1 and Coll2-1NO2 during the development of OA
induced by the transection of the anterior cruciate ligament (ACL)
in dog. The concentrations of biomarkers were correlated with the
macroscopic and histological changes that occurred in this model.
This study aimed at adding important details for the validation of
these speciﬁc OA biomarkers.
Materials and methods
Experimental group
Specimens used in this study were obtained from dog experi-
mental groups included in previous studies10 performed in
Arthrolab, Inc facilities in Canada.
Sixteen adult crossbred dogs (24e48 months old), weighing
25 3 kg, were used. Surgical transection of the ACL of the right knee
was performed under general anesthesia as previously reported10.
Following surgery, the dogs were housed and they had free access to
exercise in a large enclosure. All dogs exercised in exterior runs for
a 2-h period during the morning, 5 days a week (Monday to Friday).
The dogs were sacriﬁced by an intravenous injection of barbiturates
8 weeks after the surgical procedure. The study protocol was
approved by the ArthroLab Animal Protection Committee, fully
accredited by the Canadian Council on Animal Care (CCAC).ublished by Elsevier Ltd. All rights reserved.
Table I




Osteophytes (mm) 6.82  0.60
Size of lesions (mm2) 63.57  15.89
Global macroscopic




Structure 6.2  0.4
Cellularity
Tangential 1.6  0.1
Transitional 5.4  0.3
Safranin-O staining 1.7  0.1
Pannus 0.7  0.2
Total score 15.7 ± 0.9
Values are mean  S.E.M.
Y. Henrotin et al. / Osteoarthritis and Cartilage 20 (2012) 787e790788Serum sampling
Serum samples were obtained for each dog at baseline, 2, 4, 6
and 8 weeks after surgery. Samples were kept frozen at80C until
the biomarker analysis was performed.
Macroscopic grading
Each knee was examined for gross morphologic changes.
The degree of osteophyte formation was graded by measuring the
maximal width (in mm) of the spur on both the medial and the
lateral femoral condyles, using a digital caliper (Digimatic Caliper;
Mitutoyo, Kawasaki, Japan). Cartilage changes on themedial and the
lateral femoral condyles and tibial plateaus were graded separately
as previously described11. Brieﬂy, changes to the articular surface
areaweremeasured, with results expressed inmm2. In addition, the
depth of erosions was graded on a scale of 0e4, where 0 ¼ normal
appearance of the surface, 1 ¼ minimal ﬁbrillation or a slight
yellowish discoloration of the surface, 2 ¼ erosion extending into
the superﬁcial ormiddle layers, 3¼ erosion extending into the deep
layers, and 4 ¼ erosion extending to the subchondral bone. The
cartilage macroscopic score was then calculated using the formula,
surface depth. The ﬁnalmacroscopic score consisted of the sum of
the scores (surface  depth) of each of the lesions present on the
medial and lateral femoral condyles and tibial plateaus. The total
joint score consisted of the sum of the ﬁnal scores obtained for both
condyles and the tibial plateaus.
Histologic grading
Cartilage was removed from the areas of the lesions identiﬁed
by the macroscopic grading and histologic evaluation was then
performed on sagittal sections of cartilage from the lesional areas of
the femoral condyles and tibial plateaus10. Specimens were
dissected, ﬁxed in TissuFix #2 (Laboratoires Gilles Chaput, Mon-
treal, Quebec, Canada), and embedded in parafﬁn. Serial sections
(5 mm) of parafﬁn-embedded specimenswere prepared and stained
with safranin-O. The severity of OA lesions was graded on a histo-
logic scale of 0e29, adapted from Sakakibara et al12, by two inde-
pendent observers. This scale evaluates the severity of OA lesions
based on structural changes (scale 0e10), cellular changes (scale
0e12), stainability with safranin-O (scale 0e4), and pannus
formation (0e3). The ﬁnal score corresponds to the score of the
most severe lesions. The total score corresponds to the compilation
of the score from the histologic parameters obtained from the
different compartments of the knee.
Coll2-1 and Coll2-1NO2 immunoassays
The serum concentrations of Coll2-1 and Coll2-1NO2 were
measured by two speciﬁc competitive immunoassays3. Brieﬂy,
Coll2-1 and Coll2-1NO2 conjugated to bovine serum albumin (BSA)
by BS3 were coated by adding either 100 ml of Coll2-1 conjugate at
50 ng/ml or 100 ml of Coll2-1NO2 conjugate at 8 ng/ml for 24 h at
4C. After washing, 50 ml of calibrators (synthetic peptide) or 50 ml
unknown serum samples diluted 5-fold, were applied to the wells,
followed by 100 ml either of D3 or of D37 antibody, diluted 1/40,000
and 1/250,000 respectively, and incubated 1 h at room tempera-
ture. During the procedure, a competition for binding the antibody
takes place between the immobilized peptide and the peptide
contained in the samples. After washing, 100 ml of peroxidase-
conjugated goat antibodies to rabbit IgG (Invitrogen, Belgium)
diluted 1/10,000, were incubated 1 h at room temperature. After
washing, 100 ml of freshly prepared enzyme substrate (TMB, Invi-
trogen, Belgium) were added into each well. After 15 min, thereaction was stopped with 100 ml of 4 M H3PO4. The coloration was
read with a microplate reader (Labsystem) at 450 nm, corrected for
absorbance at 650 nm. The coating buffer was a 10 mM phosphate
buffer saline (PBS), 138 mM NaCl pH 7.4. The washing buffer was
a solution of 25mM Tris, 50 mMNaCl pH 7.3. The preparation of the
standard curve, the dilutions of serum samples, of antisera and of
the secondary antibody were done in 10 mM PBS, 138 mM NaCl,
0.2% (w/v) BSA, 0.1% (v/v) Tween 20 pH 7.0 for the Coll2-1 immu-
noassay and in 50 mM Tris, 138 mMNaCl, 0.2% (w/v) BSA, 0.1% (v/v)
Tween 20 pH 8.0 for the Coll2-1NO2 immunoassay.
MPO immunoassay
The serum concentration of MPO was measured by a commer-
cially available solid phase two-site enzyme linked immunosorbent
assay according to the manufacturer’s recommendations (Elizen
MPO, Zentech SA, Liège, Belgium).
Statistical analysis
The Coll2-1, Coll2-1NO2 and MPO concentrations were expressed
asmedian (minimumandmaximum). Statistical analyseswere carried
out with GraphPad InStat3. Friedman test followed by the Dunn’s
multiple comparison post-test were used to analyze the variation of
the biomarker concentration. Correlations between biomarkers and
the other evaluated parameters were established using the non-
parametric Spearman’s rank correlation coefﬁcient. Data were
considered statistically signiﬁcant when P value was below 0.05.
Results
Macroscopical and histological analyses
The macroscopic appearance of cartilage lesions in the dog
knees 8 weeks after ACL transection corresponded to mild to
moderate OA as previously reported10 (Table I). The size of the
osteophytes was measured and reported Table I. The histological
evaluation illustrated the OA lesion observed with the macroscopic
observation. It revealed cartilage surface ﬁbrillation, changes in
cellularity and cartilage matrix discoloration (Table I). The presence
of a pannus was reported by the histological score.
Serum concentration of the studied biomarkers
Following ACL transection a signiﬁcant increase in the serum
concentrations of the three studied biomarkers was found (Fried-
man test; Coll2-1: P ¼ 0.003, Coll2-1NO2: P ¼ 0.0007 and MPO:
P< 0.0001) (Fig.1). The Coll2-1NO2/Coll2-1 ratiowas also increased
(Friedman test; Coll2-1NO2/Coll2-1; P ¼ 0.008). The concentrations
of Coll2-1 [Fig. 1(A)] and MPO [Fig. 1(C)] were signiﬁcantly
increased as early as 2 weeks after transection compared to
Fig. 1. Coll2-1 (A), Coll2-1NO2 (B) and MPO (C) serum concentrations at baseline and 2,
4, 6 and 8 weeks after ACL transection. Data are presented as bow and whiskers plot.
Data were analyzed using Friedman test followed by Dunn’s multiple comparison post-
test. P < 0.05 is considered signiﬁcant. N ¼ 16 at each time point for Coll2-1 and MPO
and N ¼ 15 at each time point for Coll2-1NO2.
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stable until sacriﬁce at week 8. The Coll2-1NO2 [Fig. 1(B)] concen-
tration was found to be signiﬁcantly increased starting at 6
(P < 0.001) and 8 weeks (P < 0.05) after transection compared to
baseline. Notably, although Coll2-1 and Coll2-1NO2 were evidently
correlated (r ¼ 0.67, P < 0.0001), Coll2-1NO2 expectedly showed
stronger associationwith MPO than Coll2-1 (r¼ 0.39, P¼ 0.0005 vs
r ¼ 0.22, P ¼ 0.055, for Coll2-1NO2 and Coll2-1, respectively).
Correlation of biomarkers with macroscopic lesions and cartilage
histological scores
A positive and highly signiﬁcant correlation was found between
Coll2-1 concentrations (from 4 weeks until 8 weeks) and the global
macroscopic score (4 weeks: r ¼ 0.54, P ¼ 0.029; 6 weeks: r ¼ 0.50,P ¼ 0.045; 8 weeks: r ¼ 0.79, P ¼ 0.0002). Interestingly, the same
correlation was found between Coll2-1 concentration (from
2 weeks until 8 weeks) and the size of the cartilage lesions
(2 weeks: r¼ 0.62, P¼ 0.009; 4 weeks: r¼ 0.60, P¼ 0.013; 6 weeks:
r ¼ 0.50, P ¼ 0.044; 8 weeks: r ¼ 0.80, P ¼ 0.0002). Coll2-1
concentration at 8 weeks was also found to be signiﬁcantly corre-
lated with the changes in cartilage structure as evaluated by
the histological score (r ¼ 0.54, P ¼ 0.028). On the other hand,
Coll2-1NO2 concentrations were found to be signiﬁcantly corre-
lated with the size of the osteophytes (baseline: r¼ 0.70, P¼ 0.003;
2 weeks: r ¼ 0.57, P ¼ 0.02; 4 weeks: r ¼ 0.60, P ¼ 0.017; 6 weeks:
r ¼ 0.72, P ¼ 0.002; 8 weeks: r ¼ 0.67, P ¼ 0.006). At 8 weeks, the
ratio Coll2-1NO2/Coll2-1 was correlated with the global macro-
scopic score (r ¼ 0.6929, P ¼ 0.0042), the size of the macroscopic
lesions (r ¼ 0.5643, P ¼ 0.0284) and the total histological score
(r ¼ 0.6206, P ¼ 0.0136), but not with the osteophyte size.
Discussion
There is a need for reliable OA biomarkers that could detect the
early changes that take place during the disease process and that
could also monitor the disease progression. Coll2-1 and Coll2-1NO2
represent a double interest since they reﬂect not only cartilage
degradation but also inﬂammation and oxidative stress, key features
of OA and are considered biomarkers of cartilage catabolism13. These
were reported to be useful to assess the diagnosis, the burden of
disease, the prognosis by the burden of disease, investigative, prog-
nosis, efﬁcacy of treatment, diagnosis (BIPED) classiﬁcation2 and
were recently proven reliable to assess the efﬁcacy of intervention14.
This study showed that both biomarkers were increased after
the transection of ACL in dogs. The increase in the level of Coll2-1
was seen as early as 2 weeks after surgery. The importance of
collagen degradation through the activation of speciﬁc proteolytic
enzymes, e.g., matrix metalloproteases, cathepsin K or aggreca-
nases, has already been demonstrated in the ACL transection dog
model of OA15,16. In addition, this ﬁnding is in accordance with the
concept that damage to the collagen network would occur early in
the OA process. In addition, this hypothesis is supported by the
previous data obtained in the Hartley guinea pig OA model7 in
which serum Coll2-1 level increase is related to early detectable
type II collagen molecule degradation. The precocity of Coll2-1
variation accounted for the validation of this biomarker. Further-
more correlations showed that Coll2-1 reﬂected both macroscopic
and histological changes as its concentrations were signiﬁcantly
correlated with both parameters. These results conﬁrmed the
previous observations made in a well-validated guinea pig model7
in which Coll2-1 increase was shown to be associated with the
appearance of early disruption of collagen ﬁbrils and correlated
with histological severity of cartilage lesions.
The level of Coll2-1NO2was found to be increased throughout the
study period to reach its maximum levels 6 and 8 weeks after
surgery. Coll2-1NO2 reﬂects the oxidative stress that occurs in the
joint during OA. Based on previous studies in animals and human,
the ratio Coll2-1NO2/Coll2-1 has been considered to reﬂect the
oxidative stress related to inﬂammation. One may therefore expect
a strong correlation of the ratio with oxidative stress parameters.
This statement is supported by the correlation found between Coll2-
1NO2 andMPO, another marker of oxidative stress, even if it requires
further investigations. In contrast, the ratio Coll2-1NO2/Coll2-1
changes over time was negatively correlated with histological and
macroscopic parameters. This is explained by the fact that the
increase of Coll2-1 concentration over time was more important
than the increase of Coll2-1NO2. The present results showed that
Coll2-1NO2 is also associated with osteophytes formation, a process
involving nitric oxide. One may also suggest that the biomarker
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that takes place for the development of osteophytes. However, this
observation needs to be further studied. Finally, this is important to
note that MPO was note correlated with either of the OA evaluated
parameters, meaning that it is not a speciﬁc marker of OA.
Whereas interesting, this is important to pursue these investi-
gations in order to test the variations of both biomarkers in longer
range studies and in comparisonwith a control group. In addition, it
would be valuable to measure their variations in a DMOAD study.
In conclusion, this study added information regarding the validity
of these two OA biomarkers, i.e., Coll2-1 and Coll2-1NO2. These
results showed that they clearly reﬂect key events that happened in
the knee joint during the development of OA in animal model. They
should be further studied in human in order to test their ability to
detect early structural cartilage changes and to reﬂect the natural
course of OA and to complete our previous work in human9.
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